Monopar Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | +176.2% | +5,406.2% | -88.5% | +10.9% | +106.5% | +59.7% | +16.9% | -26.2% | +132.2% | +76,051.3% | |
| – | +55.4% | +27.8% | +39.6% | +44.6% | +3.8% | +7.8% | +11.8% | +9.7% | -2.3% | +215,386.7% | |
| – | +73.2% | +1,291.9% | -79.5% | +27.1% | +50.5% | +40.2% | +15.4% | -16.2% | +83.0% | +3.4% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +567.2% | +113.9% | -4.2% | -17.2% | -70.7% | -11.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | – | -262,788.1% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -95,450.0% | – | – | – | – | – | – | – | – | – |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.